Ünsel-Bolat, Gül http://orcid.org/0000-0002-4574-421X
Ercan, Eyüp Sabri
Bolat, Hilmi
Süren, Serkan
Bacanlı, Ali
Yazıcı, Kemal Utku
Rohde, Luis Augusto
Article History
Received: 19 November 2018
Accepted: 18 March 2019
First Online: 25 March 2019
Compliance with ethical standards
:
: Eyüp Sabri Ercan is on advisory boards for Sanofi Turkey. Luis A. Rohde has received honoraria, has been on the speakers’ bureau/advisory board and/or has acted as a consultant for Eli-Lilly, Janssen-Cilag, Medice, Novartis and Shire in the last three years. He receives authorship royalties from Oxford Press and ArtMed. He also received travel awards for taking part of 2014 APA and 2015 WFADHD meetings from Shire and 2016 AACAP meeting from Novartis. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by him received unrestricted educational and research support from the following pharmaceutical companies in the last three years: Eli-Lilly, Janssen-Cilag, Novartis and Shire. Gül Ünsel Bolat received travel award for taking part of 2018 Turkish Child and Adolescent Psychiatry Congress from Sanofi. The other authors declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.